Latest filing published 17 Nov 2011 for OPTIMER PHARMACEUTICALS INC, €3,988.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
John D. Prunty: trading record in brief
Filings by John D. Prunty span 2 companies, the busiest being Optimer Pharmaceuticals Inc and Maxim Pharmaceuticals Inc. Between 4 January 2006 and 15 November 2011, the trades on record add up to 10 filings.
Every open-market trade on record is a purchase: 3 purchases worth €21k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
A typical purchase (the median) is worth €7,498.
The record was last updated on 17 November 2011 with a transaction (€3,988) in Optimer Pharmaceuticals Inc. The last purchase on record was published on 22 December 2008, which is 6,531 days ago. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to John D. Prunty
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 559 shares@ US$9.72Common stockSEC:0001142576-11-000035:0
- 1,928 shares@ US$7.71Common stockSEC:0001142576-11-000022:0
- 1,303 shares@ US$7.71Common stockSEC:0001142576-10-000039:0
- 1,344 shares@ US$9.57Common stockSEC:0001142576-10-000028:0
- 1,261 shares@ US$9.91Common StockSEC:0001142576-09-000025:0
- 1,712 shares@ US$7.23Common StockSEC:0001142576-09-000018:0
- 1,942 shares@ US$6.18Common StockSEC:0001142576-08-000020:0Canonical exit: 15 Feb 2009 (T+90)
- 1,936 shares@ US$6.04Common StockSEC:0001142576-08-000016:0Canonical exit: 13 Aug 2008 (T+90)
- 4,042 sharesCommon StockSEC:0001104659-06-001044:0
9 of 9 declarations
